-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Nautilus Biotechnology, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
- Nautilus Biotechnology, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.7M, a 41.7% increase year-over-year.
- Nautilus Biotechnology, Inc. annual Operating Lease, Payments for 2023 was $6.2M, a 59% increase from 2022.
- Nautilus Biotechnology, Inc. annual Operating Lease, Payments for 2022 was $3.9M, a 117% increase from 2021.
- Nautilus Biotechnology, Inc. annual Operating Lease, Payments for 2021 was $1.8M, a 10% decline from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)